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Abstract 
Background: To study prevalence of Vancomycin 
resistant Enterococcus in different wards of hospital 
and associated risk factors. 
Methods:Samples were collected from different 
wards 110 positive samples were analyzed. To isolate 
the organism, samples were streaked on Blood and 
CLED medium and identified with specific colony 
characteristics and further confirmed by biochemical 
tests. Vancomycin drug sensitivity was performed on 
Mueller-Hinton agar plates by disc diffusion 
method. 
Results:Out of 110 Enterococcus positive samples 
32% showed resistance to Vancomycin. E. 
faecalis(67%) was observed as frequently present 
organism followed by E. faecium (33%). Most of the 
VRE strains were isolated from patients admitted to 
ICU (54%), hospitalized for more than one week and 
were on antibiotics. 
Conclusion: Vancomycin resistant Enterococcus 
becomes an important issue for the health 
authorities. Lack of basic health necessities, 
unskilled medical staff and unnecessary medication 
are mentionable concerns, leading to the  
development of resistant strains. 
Key Words: Vancomycin, Enterococcus, 
Nosocomial infection, Antibiotic resistance 
 
Introduction 
In this era of drug resistance, nosocomial or hospital 
acquired infections are the real threat to patient`s 
health and life. Among these infections Vancomycin 
resistant Enterococcus has been upraised as the utmost 
and important nosocomial infection. Emerging 
Vancomycin resistant Enterococcus is causing 
problems due to its natural resistance to many 
antibiotics. The advancement in the medical field and 
substantial rise in the use of antimicrobials put 
immense pressure 1 Bacteria has immense capability of 
handling any situation and causing drug resistance 
against almost every antimicrobial agent. 1 
Vancomycin is a glycopeptide, and was used as a drug 
of last choice against resistant gram positive strains. 
Initially Vancomycin was considered as a good 
therapy against organisms but now resistance has 
already been enused.2 Enterococcus was the first 
resistant organism followed by S.aureus.3 Since then 
Vancomycin resistant Enterococcus (VRE) are now 
considered as important nosocomial pathogen and 
have great concern for the health authorities. This 
emerging organism is omnipresent in hospital 
atmosphere particularly on medical equipment and 
objects.4 Even it can be transferred through medical 
personal directly.5,6 Natural and acquired resistance to 
many antimicrobials7 and capability of transferring 
resistant gene to other organisms modulating towards 
increased mortality and morbidity due to VRE. 7-9  
The gram positive, Enterococci which is a part of gut 
normal flora is an important cause of nosocomial 
infections. Initially Enterococcus was considered as 
harmless pathogen.10  with advancement in health 
facilities and emergence of drug resistance 
Enterococcus is now appraise as important nosocomial 
pathogen.11 Though many different species of 
Enterococcus has been isolated but only two 
Entercocccus faeclis and Enterococcus faecium are the 
important pathogenic strains. Urinary tract infections 
are the most frequent nosocomial infection caused by 
the Enterococcus followed by post-surgery wound or 
intra abdominal and intra pelvic abscess and 
endocarditis. 10 Gastrointestinal tract, soft tissues and 
skin are the primary sites for the colonization of 
Enterococcus. The risk factors associated with the 
Vancomycin resistant Enterococcous (VRE) includes  
hospitalizations length, use of other antibiotics, 
catheterization and other comorbidities like diabetes, 
renal failure etc.11-13 
 
Patients and Methods 
Current study was structured to study the prevalence 
of vancomycin resistant strains of Enterococcus in 
hospital setting. For this purpose samples were 
collected from Civil hospital Karachi and Zubaida 
Medical Centre. The samples were collected from 
March 2016 till April 2018. Samples were collected 
from the patients whose age ranged from 5-90 years 
admitted to hospital`s medicine, surgery and ICU 
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wards. Patients suffering from cancers, menstruating 
women and toddlers were not included in this study. 
In this study two parameters length of stay at hospital 
and use of antibiotics were considered.  Blood,urine 
and pus samples were streaked on Blood agar and 
CLED medium and organism were identified based on 
particular clonial characters and gram staining. For 
further confirmation litmus milk test was performed 
.Vancomycin susceptibility was performed by disc 
diffusion method on Mueller-Hinton agar plates 
(Oxoid) after making bacterial lawn with the help of 
sterile cotton swab where bacterial suspension of 0.5 
McFarland index was used.14 Plates were observed 
and clear area around discs was noted after 24 hours 
of incubation at 37°C and results were understood by 
CLSI.15.E. faecalis ATCC 29212 was considered as 
reference strain for antibiotic susceptibility testing. 
 
Results 
A total of 110 positive samples were analyzed in this 
study. Among 110 positive samples 46% (51) positive 
isolates were from male and 54% (59) from female 
patient. Most of the organisms isolated from patients 
having age group ranged from 21-30 years followed by 
61-70 years. The mean age calculated was 34 years. 
(Table 1).In present study E.faecalis (67%) was the 
most common isolated organism (Table 2). No other 
spp of Enterococcus were isolated in present study. 
Isolates from different wards revealed, Medicine (47%) 
being highest,  wards followed by ICU (35%) (Table 
3).Current results revealed 82.6%( n= 62) E.faecalis 
isolated from urine samples and 64 %(n=18) E.faecium 
from wound or pus (Table 4).Among 110 positive 
samples, 35 (32%) samples showed resistance from 
Vancomycin.  Resistance was noted 54% in E.faecalis  
and 45% E.faecium(Table 5). In current study VRE 
were isolated in 54%(n=19) patients admitted in 
hospital for more than one week 40% (n=14)from 
patients taking antibiotics for more than one week 
(Table 6) 
 
Table  1: Frequency of Enterococcus in different age 
groups 
Age in 
years 
Sex 
5-
10 
11-
20 
21-
30 
31-
40 
41-
50 
51-
60 
61-
70 
71-
80 
81-
90 
Total 
Male 02 06 07 08 06 07 11 01 03 51 
Female 02 02 10 13 10 05 09 03 05 59 
Total 04 08 17 21 16 12 20 4 08 110 
 
Table  2: Frequency of Enterococcus spp 
Name of organism % of organism 
E.faecalis 67  (n=74) 
E.faecium 33  (n=36) 
Table  3: Frequency of Enterococcus species strains 
from different wards 
Name of ward % of isolates 
Medicine 47% (n=52) 
ICU 35% (n=38) 
Surgery 18% (n=20) 
Table 4: Number of isolated Enterococcus species 
from different samples 
Name of  
organisms 
Urine  
sample 
Blood 
sample  
Wound or 
pus sample 
E.faecalis 62 2 10 
E.faecium 13 5 18 
Table 5: Number of Vancomycin resistant 
Enterococcus from different samples 
Name of 
organisms 
Urine 
sample 
Blood 
sample 
Wound or pus 
sample 
E.faecalis 15 0 4 
E.faecium 6 2 8 
Table 6: Number of patients observed VRE having 
risk factors 
Risk factors Three 
days 
Five 
days 
More than 
one week 
Length of stay at 
hospital 
5 11 19 
Use of Antibiotics 10 11 14 
 
Discussion 
 The current study is focusing on the prevalence of 
VRE strains in hospital settings. The prevalence of 
VRE has been reported in different parts of world 
including   Asia, Australia and even America. 16 In 
current study 32% (n= 35) isolated Enterococcus 
showed resistance to Vancomycin. In 2016 Akhtaret 
al., demonstrated 41.4% Vancomycin resistant 
Enterococcus strain among cancer patients, Babar et al 
(2015) stated 11% VRE .17,18  Whereas Asifet al (2014) 
noticed 16% VRE in Lahore, Pakistan.19  Our results 
were in accordance with the U.S CDC which coted 
30% -35%VRE.20,21 In contrast 4% VRE was 
documented by the European Antimicrobial 
Resistance Surveillance System (EARSS).2 
Recent study demonstrated 54% vancomycin resistant 
in E.faecalis and 45% in E.faecium. A study conducted 
in Germany by Behnkeet al., quoted 23% 
reistantE.faecium.22 In 2015 a research in Australia 
showed 48.7– 56.8% resistance among E. faecium .23 
The prevalence of E. faecalis and E.faecium was 
observed 67% and 33% in present study. Our results 
were in close association with the research conducted 
in Iran.24 
 In present study E.faecalis was the frequently isolated 
organism from the urine samples. In present study 
most of the organisms were isolated from Medicine 
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ward (47%). This could be due to large flow of patients 
in Medicine ward. Moreover lack of basic health 
facilities, more inclination towards consultants rather 
than general practitioner (GP) are also a contributing 
towards more inflow of patients in hospital settings. 
The VRE strains were mainly isolated from ICU (54% 
where n=19) in current study. National Nosocomial 
Infections Surveillance (NNIS) stated 28% VRE isolates 
were from ICU.25 Nele and his co workers (2011) 
described VRE as second most common occurring 
organism in ICU settings.26 Although Kampmeier et al 
described 3% VRE in ICU.27 Reasons for ICU being a 
prime unit for nosocomial infections and drugs 
resistant strains are more invasive procedures, 
severely ill patients, immunosuppression etc.28 In 
recent project 54% and 40% VRE strains were isolated 
from the patients having more than one week 
hospitalization and use of antibiotics history.This is 
most probably due to colonization of gastrointestinal 
tract by the opportunistic Enterococcus along with 
other factors. Unfortunately in present study, limited 
information was available regarding history of patient. 
Another important reason for the escalation of VRE 
incidence is the overwhelmed utilization of 
antimicrobials.29,30 Particularly in our setup, 
cephalosporins and floroquinolones are the most 
frequently prescribed antibiotics for every disease in 
both hospital and community settings.  This menacing 
situation has left few options available for the 
treatment of resistant infections. In addition to this 
transfer of resistant gene from Enterococci to 
Staphylococcus is also putting immense pressures on 
the emerging of VRE.3,8 This requires the stewardship 
in prescribing antibiotics and genetic transfer of 
resistant strain. Reason for high prevalence of VRE in 
Pakistan might be lack of skilled medical personal, 
limited health facilities, improper personal hygiene. 
All emphasis should be given for prevention of VRE in 
hospital settings and guidelines and awareness 
programs should be constructed for this 
 
Conclusion 
1.Vancomycin resistant Enterococcus has becomes a 
challenging issue for the health authorities.  
2.Lack of basic health necessities, unskilled medical 
staff and unnecessary medication are serious concerns 
for the development of resistant strains 
3.It is required to construct better approach in context 
of direct contact preventive measures, proper 
disinfection of apparatus and medical personnel 
hygiene and protection.  
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